Plagiarism Policy

The Editorial Board of the Journal of Pharmademica stated that plagiarism was unacceptable therefore the following policy was established which states certain actions (punishments) when plagiarism is identified in an article submitted for publication in the Journal of Pharmademica

All manuscripts will be pre-screened for plagiarism checks using the Turnitin Software. The screening process will be carried out by the Editor after the manuscript is accepted.



Plagiarism is plagiarism or taking essays, opinions, and so on from other people and making them look like their own compositions and opinions. Plagiarism can be considered a criminal offense for stealing someone else's copyright.


Papers must be original, unpublished, and not pending publication elsewhere. Any material taken verbatim from another source needs to be clearly identified as distinct from the existing original text by (1) indentation, (2) use of quotation marks, and (3) identification of the source.

Any text in excess of fair use standards (here defined as more than two or three sentences or the equivalent) or any graphic material reproduced from another source requires permission from the copyright holder and, where applicable, the original author and also requires source identification; for example, previous publications.

When plagiarism is identified, the Editor in Chief is responsible for reviewing this paper and will approve action according to the level of plagiarism detected in the paper according to the following guidelines:

Plagiarism Rate

1. Small:
Short sections from other articles were plagiarized without any significant data or ideas taken from other papers

Action : A warning is given to the author and a request to change the text and properly cite the original article is made

2. Medium:
Most of the papers are plagiarized without proper citations to the original papers

Action: The submitted article is rejected and the author is prohibited from submitting further articles for one year

3. Severe:
Most papers are plagiarized involving reproduction of original results or ideas presented in other publications

Action: The paper is rejected and the author is prohibited from submitting further articles for five years.

It is understood that all authors are responsible for the content of the papers they submit because the authors sign the Authenticity Form submitted to the Pharmademica Journal.

If the case of plagiarism occurs twice by the same author, the decision on the action to be applied will be made by the Editorial Board (Chief Editor, and Editor-in-Chief) with the Chief Editor. The author(s) may be prohibited from submitting further articles in perpetuity.

This policy also applies to material reproduced from other publications by the same author. If an author uses previously published text or images, the appropriate paragraph or image must be identified and previous publications referenced. It is understood that in the case of review papers or papers of a tutorial nature, most of the material has been previously published.

Authors must identify the source of previously published material and obtain permission from the original author and publisher. If an author submits a manuscript to the Pharmademica Journal with a significant overlap with a manuscript submitted to another journal concurrently, and this overlap is discovered during the review process or after publication of both papers, the editor of the other journal is notified and the case is treated as a case of severe plagiarism. Significant overlap means the use of identical or nearly identical images and identical or slightly modified text for one half or more of the paper. For self plagiarism less than half of the paper but more than one tenth of the paper, the case will be treated as intermediate plagiarism. If the self plagiarism is limited to the method part, the case will be considered as minor plagiarism.

If an author uses some previously published material to clarify the presentation of new results, the previously published material must be identified and its differences from this publication stated. Permission to republish must be obtained from the copyright holder. In the case of a manuscript originally published in conference proceedings and subsequently submitted for publication in the Pharmaemica Journal either in the same form or in an expanded form, the author must identify the name of the conference proceedings and the date of publication and obtain permission to republish from the copyright holder. The editor may decide not to accept this paper for publication. However, an author is permitted to use material from the unpublished presentation, including visual displays, in subsequent journal publications. In the case of a submitted publication that was originally published in another language, the title, date and journal of the original publication must be identified by the author, and copyright must be obtained. Editors may accept the publication of such translations to attract the attention of a wider audience. Editors may select certain published papers (eg "historic" papers) for republishing to provide a better perspective on a series of papers published in a single issue of the Environmental Science Bulletin. This reissue must be clearly identified and the date and journal of the original publication given, and permission from the author and publisher must be obtained.

The Pharmademica Journal layout editor is responsible for maintaining a list of penalized authors and will check for the presence or absence of author names on papers cited in the bibliography. If there is an error in the submitted paper, the layout editor will notify the Editor in Chief who will take appropriate action. This policy will be posted on the website in instructions for submitting a manuscript, and a copy will be sent to authors with a confirmation email upon receipt of their original manuscript. A sentence will be added to the copyright transfer form to indicate that the author has read the Plagiarism Policy.